Home » Clemson, Diversa join to develop nutrition-enhancing enzymes
Clemson, Diversa join to develop nutrition-enhancing enzymes
06/02/2005Clemson University (Clemson, S.C.) and Diversa Corporation (San Diego, Calif.) announced June 2 that they are collaborating to assess opportunities to leverage existing Diversa enzymes that have the potential to enhance human nutrition. The parties will initially focus on evaluating the ability of protein supplements to food to improve stamina and alertness and reduce fatigue.
Clemson scientists have ongoing programs to investigate diet and health, including the study of herbal remedies. Diversa is interested in improving the nutritional impact of food by using novel enzymes. Merging the benefits of diet with pharmaceuticals and modern genomic tools has created a rapidly growing global business area in nutrition. The Institute of Nutraceutical Research at Clemson is focused on deploying new technology to meet the needs of this new field. Diversa has developed a portfolio of commercialized enzyme products and an extensive pipeline of candidate enzymes and other proteins with industrial, chemical, agricultural, and pharmaceutical applications that have potential applications in diet and nutrition.
"Diversa's strengths in discovery and optimization of novel proteins are highly complementary with Clemson's research capabilities in nutrition, animal science, biochemistry, and chemical engineering," said David Gangemi, Ph.D., director of Clemson's Institute of Nutraceutical Research. "Diversa's well-established capabilities allow our institute to rapidly test and develop new nutraceutical compounds and be more competitive in federal grant programs."
"Clemson University and The Institute of Nutraceutical Research have developed impressive capabilities to accelerate the practical deployment of new technology aimed at improving human nutrition," said Jay M. Short, Ph.D., Diversa's president and CEO. "The Institute's ability to organize and run clinical testing programs and their established packaging and formulation expertise will help bring novel protein solutions to the consumer in a rapid, effective, safe, and economical process. We are excited about working with Clemson on proteins we are currently developing as well as working together to improve the competitiveness of both of our federal grant programs to develop new technologies."
A key goal of Clemson's expanding biotechnology program is to enhance the economy of South Carolina by developing public-private research collaborations. SC Bio, under the direction of the Institute of Nutraceutical Research, supports development of private corporate research and funding relationships.
"Our emerging relationship with Diversa represents an important corporate research collaboration in the life science industry. We believe this type of alliance will be pivotal in advancing research and creating new commercial avenues for South Carolina technologies," said SC Bio CEO Karl Kelly, Ph.D. "This is the result of South Carolina's continued efforts to attract and cultivate this industry to the state."
Additional information is available at Diversa's website: www.diversa.com. For more on Clemson's Institute of Nutraceutical Research, e-mail email@example.com or visit www.clemson.edu/INR.
Raft of Executive Changes at Hershey
Same president/CEO, but numerous internal promotions.
Campbell to Acquire Plum Organics
No. 2 organic baby food company moves Campbell in a new direction.
PepsiCo Stock Hits 32-Year High, but Why?
Decent first quarter but also investment firms buys a big stake.
Happy Family Bought by Groupe Danone
Dannon parent acquires 92 percent of seven-year-old toddler food company.
Anuga 2013: A Taste of Global Innovations Set to Take Place October 5-9
The huge global food show will be October 5-9 in Cologne, Germany.
Vermont Passes Genetic Labeling Bill
The Vermont House of Representatives approved H.112 on May 10. The bill will go to the senate next in fall 2013. If passed, the earliest the act could become law is January 2014.
GMO Labeling Effort Reaches Washington
Senate and House bills would require the FDA to develop regulations for the labeling of food containing bioengineered ingredients.
Burger King CEO To Take Over at Heinz
Bernardo Hees of 3G Capital is new CEO of Pittsburgh acquisition.
The New Hostess Company Resumes Operations
The Metropolous-Apollo-controlled company plans to reopen four plants and hire workers, but not union labor.
- 04/19/2013 Cheesemaker, Restaurant Chain Hold Mac and Cheese Cookoff
- All news »
Access Food Processing and Wellness Foods magazines on-line and receive an e-mail each month when your new issue is ready. Subscribe Now »
Biweekly updates delivering feature articles, top industry news, company news, product announcements, technical issues and more. Subscribe Now »